Gerard C, Hugli T E
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1833-7. doi: 10.1073/pnas.78.3.1833.
A functionally active and potentially lethal fragment of the fifth component of complement (C5) is generated during complement activation in serum from animals of various species. This factor, termed the "classical" anaphylatoxin, was isolated from porcine serum and was identified chemically as the des-Arg derivative of the well-characterized C5a molecule. Unlike the C3a and C4a anaphylatoxins, porcine C5a does not require the COOH-terminal arginyl residue for spasmogenic activity. Further degradation of porcine des-Arg(74)-C5a by carboxypeptidase Y removed glycine-73 and leucine-72 and decreased the intrinsic spasmogenic activity by >90%. Hence, we conclude that, although the arginyl residue is not essential, the COOH-terminal sequence Leu-Gly-Arg contributes structural information that accounts for >90% of C5a activity. Human des-Arg(74)-C5a, like its porcine counterpart, has instrinsic anaphylatoxin activity; however, higher concentrations were needed to contract the guinea pig ileal tissue (i.e., 1 muM for human des-Arg(74)-C5a versus 1 nM for porcine des-Arg(74)-C5a). Furthermore, the des-Arg form of human C5a was only 0.1% as active as porcine des-Arg(74)-C5a for enhancing vascular permeability in guinea pig skin. In addition to these biological differences, numerous chemical differences exist between the human and porcine des-Arg(74)-C5a molecules, the most prominent feature being an oligosaccharide entity associated uniquely with the human C5a. When the oligosaccharide unit of human des-Arg(74)-C5a was removed by glycosidases, leaving a single glucosamine residue attached to the side chain of asparagine-64, activity was enhanced. The human des-Arg(74)-C5a molecule devoid of the complex oligosaccharide unit exhibited 10-fold stronger spasmogenic activity and 20- to 50-fold greater permeability-enhancing activity than did human des-Arg(74)-C5a containing the oligosaccharide. Consequently, the oligosaccharide associated with human C5a modulates or suppresses potentially harmful activities of this anaphylatoxin. The relatively high levels of spasmogenic activity associated with porcine des-Arg(74)-C5a indicate that this factor is poorly controlled by endogenous serum carboxypeptidase, whereas human C5a is virtually inactivated by the enzyme. Hence, the influence of this oligosaccharide in suppressing human des-Arg(74)-C5a activity is of major physiologic importance in protecting man from potentially toxic effects of this complement factor.
在不同物种动物的血清补体激活过程中,会产生一种具有功能活性且可能具有致死性的补体第五成分(C5)片段。这个因子被称为“经典”过敏毒素,从猪血清中分离出来,经化学鉴定为特征明确的C5a分子的去精氨酸衍生物。与C3a和C4a过敏毒素不同,猪C5a的致痉活性不需要COOH末端的精氨酰残基。羧肽酶Y对猪去精氨酸(74)-C5a的进一步降解去除了甘氨酸-73和亮氨酸-72,并使内在致痉活性降低了90%以上。因此,我们得出结论,虽然精氨酰残基并非必需,但COOH末端序列Leu-Gly-Arg提供的结构信息占C5a活性的90%以上。人去精氨酸(74)-C5a与其猪对应物一样,具有内在过敏毒素活性;然而,收缩豚鼠回肠组织需要更高的浓度(即人去精氨酸(74)-C5a为1μM,而猪去精氨酸(74)-C5a为1 nM)。此外,人C5a的去精氨酸形式在增强豚鼠皮肤血管通透性方面的活性仅为猪去精氨酸(74)-C5a的0.1%。除了这些生物学差异外,人及猪去精氨酸(74)-C5a分子之间还存在许多化学差异,最显著的特征是与人C5a独特相关的一个寡糖实体。当人去精氨酸(74)-C5a的寡糖单元被糖苷酶去除,仅留下一个连接在天冬酰胺-64侧链上的葡糖胺残基时,活性增强。不含复杂寡糖单元的人去精氨酸(74)-C5a分子的致痉活性比含寡糖的人去精氨酸(74)-C5a强10倍,通透性增强活性高20至50倍。因此,与人C5a相关的寡糖调节或抑制了这种过敏毒素的潜在有害活性。与猪去精氨酸(74)-C5a相关的相对较高水平的致痉活性表明,该因子受内源性血清羧肽酶的控制较差,而人C5a实际上会被该酶灭活。因此,这种寡糖在抑制人去精氨酸(74)-C5a活性方面的作用在保护人类免受这种补体因子潜在毒性影响方面具有重要的生理意义。